BHVN Q2 2022 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$197M

Net Income

-$203M

EPS (Diluted)

$-5.67

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$68M

Free Cash Flow

-$104M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$98M

Total Liabilities

$73M

Stockholders' Equity

$25M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$93M	-100.0%
Gross Profit	$0	$76M	-100.0%
Operating Income	-$197M	-$172M	-14.7%
Net Income	-$203M	-$211M	+3.5%

Revenue Segments

Product

$194M100%